Search results
...Trip Up After FDA Advisors Reject MDMA For PTSD Treatment - ATAI Life Sciences (NASDAQ:ATAI),...
Benzinga· 20 hours agoA panel of advisors to the Food and Drug Administration (FDA) rejected MDMA as a treatment for...
Panel rejects psychedelic drug MDMA as a PTSD treatment in possible setback for advocates
AOL· 2 days agoA first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was roundly criticized Tuesday — a potentially major setback ...
Psychedelic stocks fall as FDA regulatory advisers fail to back MDMA-based PTSD treatment
Investing.com· 1 day agoPsychedelic stocks fall as FDA regulatory advisers fail to back MDMA-based PTSD treatment
FDA Panel Rejects Use of MDMA-Assisted Therapy for PTSD
Healthline via AOL· 1 day agoAn expert panel of the Food and Drug Administration reviewed finding from two phase 3 clinical...
MDMA therapy wait goes on as FDA panel rejects Lykos’ PTSD treatment
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe two companies will pursue neuroplastogens – agents that induce rapid and long-lasting...
US FDA panel votes against first MDMA-based PTSD treatment By Reuters
Investing.com· 2 days agoThe panel voted 10-to-1 against the first MDMA-based PTSD treatment, saying the benefits did not...
US FDA panel votes against first MDMA-based PTSD treatment
Reuters via Yahoo News· 2 days agoThe panel voted 10-to-1 against the first MDMA-based PTSD treatment, saying the benefits did not...
Panel rejects psychedelic drug MDMA as treatment for PTSD
Anchorage Daily News· 1 day agoA first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was...
FDA rejects MDMA drug for PTSD
WDVM via Yahoo News· 22 hours agoAn FDA panel has rejected a first-of-its kind proposal to use the psychedelic drug MDMA as a treatment for PTSD, which could have a major impact on those...
Ecstasy as a PTSD treatment gets thumbs down from FDA advisers
Market Watch· 2 days agoIn votes taken late Tuesday, the majority of the FDA advisory panel’s members said the available...